These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 4566543)

  • 1. [S-adenosylmethionine in the therapy of liver insufficiency during a course of pulmonary tuberculosis].
    Durigato S
    Minerva Med; 1972 Dec; 63(91):5024-9. PubMed ID: 4566543
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemotherapy of pulmonary tuberculosis with liver damage].
    Overrath H
    Prax Pneumol; 1973 Mar; 27(3):182-90. PubMed ID: 4699468
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of the hepatotoxic effect of antituberculous drugs in tuberculosis patients abusing alcohol.
    Grymiński J; Lyczewska J; Styszewska H; Walczak J
    Pol Med J; 1970; 9(3):635-44. PubMed ID: 5452841
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and experimental studies of liver damages in tuberculosis, with special reference to liver damages caused by antitubercular agents and the autonomic nervous factor].
    Homma Y
    Iryo; 1969 Apr; 23(4):482-501. PubMed ID: 5804545
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ultrasonic examination of the liver in patients with pulmonary tuberculosis].
    Ivanov AK; Dzodzuashvili KA
    Klin Med (Mosk); 1990 Jan; 68(1):100-3. PubMed ID: 2186199
    [No Abstract]   [Full Text] [Related]  

  • 6. Liver function disorders in the course of continuous and intermittent treatment of patients with chronic pulmonary tuberculosis.
    Kucharska A
    Gruzlica; 1975 Dec; 43(12):1099-106. PubMed ID: 1193414
    [No Abstract]   [Full Text] [Related]  

  • 7. Liver function testing in African patients on treatment for tuberculosis.
    Davies PD
    East Afr Med J; 1985 Jul; 62(7):486-90. PubMed ID: 4076028
    [No Abstract]   [Full Text] [Related]  

  • 8. [Liver damage caused by the continued use of chemotherapy of pulmonary tuberculosis].
    Yamazaki M; Endo K; Noguchi T; Nakano M
    Iryo; 1966 Apr; 20(4):347-53. PubMed ID: 5974193
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of some liver function tests routinely performed in early detection of damage to liver parenchyma in patients with pulmonary tuberculosis].
    Pruszyńska S
    Gruzlica; 1971 Dec; 39(12):1205-9. PubMed ID: 5139239
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors for drug induced hepatitis with first-line antituberculosis drugs in hospitalized patients of pulmonary tuberculosis.
    Pore SM; Shinde K
    J Postgrad Med; 2014; 60(1):90-2. PubMed ID: 24625953
    [No Abstract]   [Full Text] [Related]  

  • 11. [Administration of antituberculous drugs to subjects with basic diseases. 2. Clinical studies of INH and RFP therapy on tuberculous patients with liver diseases].
    Yamazaki M
    Kekkaku; 1987 Dec; 62(12):667-71. PubMed ID: 3448352
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnosis of liver diseases in patients with pulmonary tuberculosis].
    El'kin AV; Ariél' BM; Nechaev VV
    Probl Tuberk; 1992; (7-8):15-8. PubMed ID: 1488430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The efficacy of treating patients with destructive pulmonary tuberculosis with liver involvement].
    Novozhylova IO
    Lik Sprava; 1998; (7):121-3. PubMed ID: 10050479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Liver changes during treatment with antitubercular agents].
    Velojic D; Jankovic Z; MArsenic B
    Plucne Bolesti Tuberk; 1975; 27(1-2):53-60. PubMed ID: 1161927
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effectiveness of the hepatoprotective activity of reamberine, remaxol, and ademethionine and risk assessment in their use in patients with respiratory tuberculosis and drug-induced liver injury].
    Sukhanov DS
    Ter Arkh; 2012; 84(11):26-9. PubMed ID: 23252243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolism pathways and use of heptral in chronic liver diseases].
    Il'chenko LIu; Vinnitskaia EV
    Eksp Klin Gastroenterol; 2002; (2):62-4, 103. PubMed ID: 12046390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tuberculosis and live with special reference to lesions due to antimycobacterial agents].
    Daddi G; Boccitto G; Storniello G; Salvati F
    Epatologia; 1970; 16(1):71-6. PubMed ID: 5525569
    [No Abstract]   [Full Text] [Related]  

  • 18. [Radioisotope study of liver function in drug-induced toxico-allergic reactions in patients with ruberculosis].
    Vil'derman AM; Frenkel' VKh; Reznik SE; Tikhun MN
    Med Radiol (Mosk); 1967 Apr; 12(4):62-6. PubMed ID: 6052187
    [No Abstract]   [Full Text] [Related]  

  • 19. [The anti-steatosic effect of sulfo-adenosylmethionine (SAMe) in various forms of chronic hepatopathy. Multicentric research].
    Mazzanti R; Arcangeli A; Salvadori G; Smorlesi C; Di Perri T; Auteri A; Boggiano CA; Pippi L; Toti M; Boncompagni P; Angioli D; Caremani M; Magnolfi F; Camarri E; Motta R; Forconi A; Candidi Tommasi A; Lomi M; Soldi A
    Minerva Med; 1978 Oct; 69(48):3283-92. PubMed ID: 724140
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chemotherapy of newly detected destructive pulmonary tuberculosis in patients with pathology of the gastrointestinal tract and liver].
    Potashova VA; Zhukova EM; Borovinskaia TA; Fomintseva OA; Fedorova MV
    Probl Tuberk; 1990; (7):65-6. PubMed ID: 2235957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.